News

Stay Updated! In The World Of Investments!
Sensex 57858.15 366.64 (0.64%)

UPL Latest News

09

Jun, 2021

UPL informs about analyst meet

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, UPL has informed that the Company will be participating in a conference call with Analyst/ Investors as per t...

Read More

05

Jun, 2021

UPL informs about loss of share certificates

Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, UPL has informed that the share certificate(s), as per detail...

Read More

03

Jun, 2021

UPL informs about press release

UPL has informed that it has enclosed Press Release on 2nd June 2021 titled ‘UPL, global leader in sustainable agriculture, secures ratings outlook upgrade from Fitch’.

Read More

29

May, 2021

UPL sets up oxygen plants at 8 hospitals in four states

UPL has set up oxygen plants at eight hospitals in Gujarat, Madhya Pradesh, Uttar Pradesh, and Delhi. The company has converted four of its nitrogen plants in Gujarat to produce and deliver oxygen.

Read More

14

May, 2021

UPL zooms on reporting 72% rise in Q4 consolidated net profit

UPL is currently trading at Rs. 747.50, up by 55.90 points or 8.08% from its previous closing of Rs. 691.60 on the BSE.

The scrip opened at Rs. 709.85 and has to...

Read More

14

May, 2021

UPL reports 72% rise in Q4 consolidated net profit

UPL has reported results for fourth quarter and year ended March 31, 2021.

The company has reported net loss at Rs 132 crore for the quarter under review as compared to net loss of ...

Read More

11

May, 2021

UPL moves up after its arm enters into license agreement with Meiji Seika Pharma

UPL is currently trading at Rs. 675.50, up by 1.10 points or 0.16% from its previous closing of Rs. 674.40 on the BSE.

The scrip opened at Rs. 678.20 and has tou...

Read More

11

May, 2021

UPL’s arm enters into license agreement with Meiji Seika Pharma

UPL’s subsidiary has entered into a license agreement with Japanese company, Meiji Seika Pharma for exclusive access to Flupyrimin for rice in Southeast Asia. Under the license agreement, UPL will obtain exclu...

Read More

11

May, 2021

UPL informs about press release

UPL has informed that it enclosed Press Release titled ‘UPL Announces Collaboration with Meiji for Exclusive Access to Flupyrimin Rice in Southeast Asia.'

Read More

24

Apr, 2021

UPL planning to supply oxygen to 4 hospitals in Gujarat, Madhya Pradesh

UPL is planning to produce oxygen from four of its nitrogen- producing plants in Gujarat for four hospitals in Gujarat and Madhya Pradesh amid rising cases of COVID-19. These plants will then be skid-mounted and delivered direc...

Read More